匆忙沟通与低患者自我效能与狼疮药物持续不依从的关联
研究纳入77例系统性红斑狼疮(SLE)患者,基线及约1年后随访,用自我报告和药房配药数据评估依从性。48%患者持续不依从,其更年轻、更多为黑人、收入更低、用药≥2种、基线SLE相关损伤更高、随访时医生总体疾病活动度评估更高,且更常报告匆忙沟通和用药管理自我效能更低。
要点
- 77例SLE患者中48%为持续不依从,即两个时间点自我报告和配药率均低。
- 持续不依从者更年轻、更多黑人、收入更低、用药≥2种、基线损伤更高。
- 持续不依从者报告与医生沟通更匆忙(语速快、用词难)且用药管理自我效能更低。
核心结论
- 改善用药依从性的潜在途径包括优化医患沟通(避免难懂词汇和快语速)和提升患者自我效能,尤其针对收入较低、不依从风险更高的年轻黑人患者。
研究设计与样本
- 研究纳入正在服用≥1种SLE药物的患者,基线和约1年后随访时用自我报告依从性和药房配药数据评估依从性,协变量包括医患互动、患者自我效能和临床因素。
- 用Kruskal-Wallis H检验比较3组患者特征:持续不依从(两个时间点自我报告和配药率均低)、持续依从(两个时间点自我报告和配药率均高)和不一致依从(其余患者)。
主要发现
- 77例患者(中位年龄44岁,53%黑人,96%女性)中48%为持续不依从。
- 与其他依从组相比,持续不依从者更年轻、更可能为黑人、收入更低、服用≥2种SLE药物、基线SLE相关损伤更高、随访时医生总体疾病活动度评估更高。
- 持续不依从者报告与医生沟通更匆忙(特别是语速快和用词难)且用药管理自我效能更低。
临床怎么用
- 作者认为改善用药依从性的潜在途径包括优化医患沟通(避免难懂词汇和快语速)和提升患者自我效能,尤其针对收入较低、不依从风险更高的年轻黑人患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Medication nonadherence is common among patients with systemic lupus erythematosus (SLE), and adherence often fluctuates with time. Underrepresented racial minorities have disproportionately lower rates of medication adherence and more severe SLE manifestations. We aimed to identify modifiable factors associated with persistent medication nonadherence. METHODS: Patients taking ≥1 SLE medication were enrolled. Adherence data were obtained at baseline and at follow-up roughly 1 year later using both self-reported adherence and pharmacy refill data. Covariates included patient-provider interaction, patient self-efficacy, and clinical factors. We compared characteristics of patients in 3 groups using the Kruskal-Wallis H test: persistent nonadherence (low adherence by self-report and refill rates at both time points); persistent adherence (high adherence by self-report and refill rates at both time points); and inconsistent adherence (the remainder). RESULTS: Among 77 patients (median age 44 years, 53% Black, 96% female), 48% had persistent nonadherence. Compared with other adherence groups, patients with persistent nonadherence were younger and more likely to be Black, have lower income, take ≥2 SLE medications, have higher SLE-related damage at baseline, and have higher physician global assessment of disease activity at follow-up. Persistently nonadherent patients also rated more hurried communication with providers (particularly fast speech and difficult word choice) and had lower self-efficacy in managing medications. CONCLUSION: Potential avenues to improve medication adherence include optimizing patient-provider communication, specifically avoiding difficult vocabulary and fast speech, and enhancing patient self-efficacy, particularly among younger Black patients with lower income who are at higher risk for nonadherence.
引用
- Barr AC, Clowse M, Maheswaranathan M, et al. Association of Hurried Communication and Low Patient Self-Efficacy With Persistent Nonadherence to Lupus Medications. Arthritis Care Res (Hoboken). 2022. PMID: 36194070. doi:10.1002/acr.25030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。